A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information
Clinical trial NCT05718570 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05718570
- Sponsor
- Novo Nordisk A/S
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-03
- Primary completion
- 2032-12-15
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.